drugset / Trial / NCT04462263
Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
A Study in Healthy Volunteers to Investigate How a New Drug for the Treatment of Parkinson's Disease, Dystonia and Amyotrophic Lateral Sclerosis Binds to Receptor Sites in the Brain.
Timeline
- Start
- 2020-06-29
- Primary completion
- 2021-06-23
- Completion
- 2021-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HTL0014242 | Small molecule | 1 mg | Oral |
| Subject | HTL0014242 | Small molecule | 5 mg | Oral |
| Subject | HTL0014242 | Small molecule | 10 mg | Oral |
| Subject | HTL0014242 | Small molecule | 30 mg | Oral |
| Subject | HTL0014242 | Small molecule | 120 mg | Oral |
Indications
No indication recorded.